Podcasts about Pill

01. Meduza - No Sleep 02. Kream, Camden Cox - Weightless 03. Tchami, Niiko X Swae - Waiting 04. Paul Oakenfold, Mr Belt & Wezol, Shifty Shellshock - Starry Eyed Surprise 05. Luke Miller - Make It Hot 06. Nicky Romero, Sick Individuals - Hold On 07. Dvbbs, Abi Flynn - Move A Little Closer 08. Pete Tong, Avg - Places & Spaces 09. Justluke, Inpetto, Jordy - Drowning 10. Rue Jay - I Want Your Love 11. Chris Lake, Ragie Ban - Toxic 12. Then - Lucid Ashes 13. Roger Sanchez, Fedde Le Grand - Grinnin' 14. Maxx Play, Johnny Grinch - Play Right 15. Bingo Players, Oomloud - Like This Like That 16. Markus Schulz, Matt Fax - The New World 17. Thomas Newson, Raumakustik - Gucci Belter 18. Mike Posner, Steve Aoki - I Took a Pill in Ibiza 19. Alok - Don't Mess With The Fire 20. Worakls, Apashe, Wasiu - Rome Is Burning 21. Big Gigantic, The Funk Hunters, Chali 2Na - Beat Don't Stop 22. Dominique Jardin, Cat Dealers - Up Late 23. Dubdogz, Chemical Surf, Lothief - Girl On Fire 24. D.O.D, Raphaella - Like You Do 25. Like Mike, Tom Zeta - In My Ear 26. Cosmic Gate - You 27. Egzod, Maestro Chives, Don Diablo - Royalty 28. Twin Diplomacy - I Got Feelings 29. Block & Crown, Mike Ferullo - A.C.I.D 30. Low Steppa - Holte 31. Vion Konger, Melo.Kids - Gettin' Jiggy Wit It 32. Corey James, Morganj, Tyoz - Jungle 33. Bijou, Datti - Mind Eraser 34. Dillon Nathaniel - Break The System 35. Essel, Navos - Steel Drums 36. Morten, David Guetta - Lucky 37. Smack, Djs From Mars - It Doesn't Matter 38. Jamie Jones - Murder Mystery

01. Meduza - No Sleep 02. Kream, Camden Cox - Weightless 03. Tchami, Niiko X Swae - Waiting 04. Paul Oakenfold, Mr Belt & Wezol, Shifty Shellshock - Starry Eyed Surprise 05. Luke Miller - Make It Hot 06. Nicky Romero, Sick Individuals - Hold On 07. Dvbbs, Abi Flynn - Move A Little Closer 08. Pete Tong, Avg - Places & Spaces 09. Justluke, Inpetto, Jordy - Drowning 10. Rue Jay - I Want Your Love 11. Chris Lake, Ragie Ban - Toxic 12. Then - Lucid Ashes 13. Roger Sanchez, Fedde Le Grand - Grinnin' 14. Maxx Play, Johnny Grinch - Play Right 15. Bingo Players, Oomloud - Like This Like That 16. Markus Schulz, Matt Fax - The New World 17. Thomas Newson, Raumakustik - Gucci Belter 18. Mike Posner, Steve Aoki - I Took a Pill in Ibiza 19. Alok - Don't Mess With The Fire 20. Worakls, Apashe, Wasiu - Rome Is Burning 21. Big Gigantic, The Funk Hunters, Chali 2Na - Beat Don't Stop 22. Dominique Jardin, Cat Dealers - Up Late 23. Dubdogz, Chemical Surf, Lothief - Girl On Fire 24. D.O.D, Raphaella - Like You Do 25. Like Mike, Tom Zeta - In My Ear 26. Cosmic Gate - You 27. Egzod, Maestro Chives, Don Diablo - Royalty 28. Twin Diplomacy - I Got Feelings 29. Block & Crown, Mike Ferullo - A.C.I.D 30. Low Steppa - Holte 31. Vion Konger, Melo.Kids - Gettin' Jiggy Wit It 32. Corey James, Morganj, Tyoz - Jungle 33. Bijou, Datti - Mind Eraser 34. Dillon Nathaniel - Break The System 35. Essel, Navos - Steel Drums 36. Morten, David Guetta - Lucky 37. Smack, Djs From Mars - It Doesn't Matter 38. Jamie Jones - Murder Mystery

In this episode, The Annuity Man discussed:  Choosing guarantees over speculation Knowing your "PILL" for protection Building your income floor Balancing risk with security   Key Takeaways:  Crypto investments are like rolling dice, while annuities provide contractual guarantees and predictable results. Building financial security means focusing on what you can count on, not what you can guess. The four reasons for owning an annuity are Principal Protection, Income for Life, Legacy, and Long-Term Care. These act as anchors for stability when market uncertainty rises. Social Security and pensions already provide a guaranteed income. Evaluating whether you need more ensures that your financial base remains steady even when the markets shake. Instead of chasing bonuses or hypothetical returns, consider moving some assets from high-risk areas like crypto into products with clear, guaranteed outcomes.   "You own an annuity for what it will do, not what it might do. The 'will do' is the contractual guarantees of the policy." —  Stan The Annuity Man   Connect with The Annuity Man:  Website: http://theannuityman.com/  Email: Stan@TheAnnuityMan.com  Book: Owner's Manuals: https://www.stantheannuityman.com/how-do-annuities-work YouTube: https://www.youtube.com/channel/UCCXKKxvVslbeGAlEc5sra2g  Get a Quote Today: https://www.stantheannuityman.com/annuity-calculator! 

Our hormones are all over the place and we're just trying to keep up. We're talking about what happens when your hormone levels start doing their own thing, how finding the right medication feels like a full-time job (and a reminder that we're absolutely not doctors, just two women trying to find the right balance), and why every Google search somehow leads to more confusion. We're also getting real about aging and the habits that actually help. Basically, if there's something you don't want to do… it probably means you should be doing it.Want our podcasts sent straight to your phone? Text us the word "Podcast" to +1 (917) 540-8715 and we'll text you the new episodes when they're released!Tune in for new Cat & Nat Unfiltered episodes every Monday, Tuesday, Thursday and Friday!Follow @catandnatunfiltered on Instagram: https://instagram.com/catandnatunfilteredOur new book "Mom Secrets" is now available! Head to www.catandnat.ca/book to grab your autographed copy! Come see us LIVE on tour!! To see a full list of cities and dates, go to https://catandnattour.com.Are you a parent that is struggling understanding the online world, setting healthy screen-time limits, or navigating harmful online content? Purchase screen sense for $24.99 & unlock Cat & Nat's ultimate guide to parenting in the digital age. Go to https://www.thecommonparent.com/screen-sense-ebookFollow our parenting platform - The Common Parent - over on Instagram: https://instagram.com/thecommonparentMake sure you subscribe to our YouTube channel: https://bitly.com/catnatyoutubeCheck out our Amazon Lives here: https://bitly.com/catnatamazonliveOrder TAYLIVI here: https://taylivi.comGet personalized videos from us on Cameo: https://cameo.com/catandnatCome hang with us over on https://instagram.com/catandnat all day long.And follow us on https://tiktok.com/@catandnatofficial! Hosted on Acast. See acast.com/privacy for more information.

Diving into the controversial world of Modafinil, the "all-nighter in a pill", Matt begins with the story of Olympic sprinters using the narcolepsy drug as a loophole for a competitive edge. He then unpacks the science of how Modafinil affects brain chemistry to boost wakefulness and cognition, tracing its evolution from a medical treatment to a performance enhancer for the military, Wall Street, and students, all attempting to push human limits by cheating sleep.Despite its potent effects, Modafinil carries significant risks and ethical dilemmas. Matt discusses its side effects, potential for psychological dependency, and the unknowns of long-term use. The episode examines complex questions of fairness and the potential for "cognitive inequality." Ultimately, Matt argues that while the drug masks fatigue, it cannot replace the vital restorative functions of natural sleep. The "sleep debt" must eventually be repaid, as true well-being depends on this biological necessity, not a pill.Please note that Matt is not a medical doctor, and none of the content in this podcast should be considered medical advice in any way, shape, or form, nor prescriptive in any way.One of this week's sponsors, LMNT, offers a science-based electrolyte drink with no sugar or artificial ingredients. Try their new limited-time Lemonade Salt flavor, available May 20th! Get eight free sample packs with any order at drinklmnt.com/mattwalker. Stock up on this summer flavor while it lasts!Another sponsor, David, is a revolutionary new protein bar developed with Dr. Peter Attia. It boasts an unbeatable ratio: 28g of protein and 0g of sugar in just 150 calories. Incredibly satiating with six amazing flavors, it's perfect for muscle health. Visit davidprotein.com/mattwalker and buy 4 cartons to get a 5th FREE!As always, if you have thoughts or feedback you'd like to share, please reach out:Matt: Instagram @drmattwalker, X @sleepdiplomat, YouTube https://www.youtube.com/@sleepdiplomatmattwalker9299

Christine Short and Scott Zari cover Eli Lilly (LLY) earnings and the future of GLP-1 drugs. Christine emphasizes the global demand for these drugs, as evidenced by higher international revenue, and what a daily oral GLP-1 pill could do for the company. Scott looks at Eli Lilly's market share in the weight loss sector, calling it a “two horse race” between them and Novo Nordisk (NVO).======== Schwab Network ========Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

Mace, Cody, and Evan look at the ethics of the government shutdown and how to "remember the Alamo." The shutdown is cutting into EBT distributions which is leading some to threaten violence and theft as a result. Healthcare is also apparently on the chopping block. Are we facing a violent and dangerous future? We also look at the Alamo "myth" and how it should be taught in schools.

Did we just unearth a banger idea for our station?

'Buenos días, Javi y Mar' informa que este jueves 30 de octubre se debate la obesidad en las Islas Canarias, con un 23% de adultos y un 35% de niños afectados, y el gobierno solicita declararla enfermedad crónica. También se analizan los precios de los alimentos en octubre, con una subida del IPC al 3% y el precio de una docena de huevos a 3,14€. Se comenta la fuerte lluvia en Sevilla y Huelva, con 100 litros por metro cuadrado en Sevilla. La noticia de unos monos escapados en Mississippi, infectados con Hepatitis C y COVID-19, causa preocupación. Se destaca la canción "Todo Contigo" de Álvaro de Luna. En CADENA 100, se debate que las personas que agradecen con la mano a los conductores son más positivas, empáticas y pacientes, y se clasifican los tipos de peatones. Se escucha "Moves Like Jagger" de Maroon 5 ft. Christina Aguilera. Se mencionan las calorías que se queman viendo películas de miedo. Pink interpreta "Just Like a Pill". En 'Buenos días, Javi y Mar', se habla sobre la ...

The investigation into the death of Celeste Rivas Hernandez, the teen whose badly decomposed body was found in the trunk of a Tesla owned by singer D4vd, is ongoing. Private investigator Steve Fischer has been investigating the case after being hired by the owner of the Hollywood Hills home where D4vd was living. Los Angeles Police are investigating Celeste's death and the medical examiner is awaiting toxicology results before determining manner and cause of death. Law&Crime's Angenette Levy talks with Fischer about his latest findings in this episode of Crime Fix — a daily show covering the biggest stories in crime.PLEASE SUPPORT THE SHOW: If you're ever injured in an accident, you can check out Morgan & Morgan. You can submit a claim in 8 clicks or less without having to leave your couch. To start your claim, visit: https://www.forthepeople.com/CrimeFixHost:Angenette Levy https://twitter.com/Angenette5Guest: Steve Fischer https://x.com/SF_investigatesProducer:Jordan ChaconCRIME FIX PRODUCTION:Head of Social Media, YouTube - Bobby SzokeSocial Media Management - Vanessa BeinVideo Editing - Daniel CamachoGuest Booking - Alyssa Fisher & Diane KayeSTAY UP-TO-DATE WITH THE LAW&CRIME NETWORK:Watch Law&Crime Network on YouTubeTV: https://bit.ly/3td2e3yWhere To Watch Law&Crime Network: https://bit.ly/3akxLK5Sign Up For Law&Crime's Daily Newsletter: https://bit.ly/LawandCrimeNewsletterRead Fascinating Articles From Law&Crime Network: https://bit.ly/3td2IqoLAW&CRIME NETWORK SOCIAL MEDIA:Instagram: https://www.instagram.com/lawandcrime/Twitter: https://twitter.com/LawCrimeNetworkFacebook: https://www.facebook.com/lawandcrimeTwitch: https://www.twitch.tv/lawandcrimenetworkTikTok: https://www.tiktok.com/@lawandcrimeSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode of Ageless Future, Regan Archibald explores the groundbreaking molecule SLU-PP-332, a compound designed to mimic the metabolic benefits of exercise by activating key genetic and mitochondrial pathways. Originally developed by researchers at St. Louis University, SLU-PP-332 works through the ERR-alpha and AMPK pathways, promoting fat oxidation, mitochondrial biogenesis, and improved insulin sensitivity—without the oxidative stress of overtraining. Regan discusses how animal studies demonstrated dramatic improvements in endurance, fat loss, and glucose control, and shares his own experience using SLU-PP-332 to enhance VO₂ max, energy, and recovery. He also outlines its potential applications for metabolic syndrome, muscle loss, inflammation, and even post-COVID mitochondrial dysfunction. The episode concludes with practical insights on stacking SLU-PP-332 with other peptides like MOTS-c, 5-Amino-1MQ, and BPC-157 for comprehensive metabolic rejuvenation, while emphasizing the foundation of longevity medicine: optimizing insulin sensitivity, mitochondrial efficiency, and consistent physical conditioning.www.agelessfuture.com

Gui Gomes, CEO of OranjeBTC, joins host Aaron Stanley to discuss his company's mission to become Latin America's leading Bitcoin adoption catalyst following their recent listing on Brazil's B3 exchange. Gomes brings a unique perspective shaped by his time at Bridgewater Associates, where working alongside Ray Dalio on global economic power shifts crystallized his conviction that Bitcoin represents the future of reserve currencies. He outlines OranjeBTC's dual mandate: building the region's largest Bitcoin treasury while delivering comprehensive education to investors at all levels. The company is actively accumulating Bitcoin through weekly purchases and exploring various capital instruments to grow their holdings, similar to strategies pioneered by MicroStrategy. Gomes shares his vision for Brazil's potential as an early Bitcoin adopter among major economies, arguing that the country's 215 million people could set a transformative example for emerging markets navigating the transition toward digital, decentralized monetary systems.You can connect with Gui on Linkedin-------------------------------------------------------------------

"PELICAN PILL" TITLED TRACK NEW SINGLE BY PELICAN PILL ROCK RAYMOND PRODUCTIONS © Copyright rockraymondproductions.com All Rights Reserved. Pelican Pill is a sonic pilgrimage—where classic rock's spiritual backbone meets the raw pulse of modern rebellion. Born from the ashes of forgotten dreams and the wings of restless visionaries, the band crafts anthems that soar, sting, and heal. Their debut single, “Feather and Flame,” channels the urgency of Kansas with a leaner, punchier frame—tight harmonies, thunderous riffs, and lyrics that wrestle with redemption, flight, and fire. It's not nostalgia—it's resurrection. Fronted by a voice that sounds like it's lived a thousand lifetimes and backed by a rhythm section that hits like prophecy, Pelican Pill doesn't just play music—they deliver medicine for the soul. Each track is a dose of truth wrapped in melody, a pill for the dreamers, the wanderers, and the ones who refuse to fall quietly. Whether on stage or in the studio, Pelican Pill is a band that believes in the power of myth, melody, and motion. Their sound is cinematic, their message timeless, and their journey just beginning. lyrics:   Woke up in the shadow of a silver tide  Dreams like anchors, pulling from the other side  Wings clipped by the weight of the world I knew  But the sky keeps calling, breaking through    (Pre-Chorus)  I've been lost in the echo of a long goodbye  Now I'm chasing the fire in a pelican's cry    (Chorus)  Feather and flame, I rise again  Burning the past like a medicine  Truth in the wind, soul on the run  Pelican Pill, I'm not done    (Verse 2)  Ghosts of glory whisper through the canyon walls  Every fall's a lesson, every rise recalls  I've seen the light bend, I've felt the sting  But I won't trade flight for anything    (Pre-Chorus)  I've been bound by the silence of a stormy sky  Now I'm riding the thunder, wings held high    (Chorus)  Feather and flame, I rise again  Burning the past like a medicine  Truth in the wind, soul on the run  Pelican Pill, I'm not done    (Bridge)  Let the waves crash, let the stars spin  I'll find my way where the edge begins  No more waiting, no more chains  I'm the echo that remains    (Final Chorus)  Feather and flame, I rise again  Burning the past like a medicine  Truth in the wind, soul on the run  Pelican Pill, I've just begun    Support us on PayPal!

Shawn & Janet Needham R.Ph. have Elizabeth Katzman on the podcast to talk about "The Pill Hangover" & hormone healing. She's a Functional Hormone Practitioner helping women in their 30s and 40s recover from what she calls “The Pill Hangover”—a cascade of symptoms like fatigue, anxiety, gut issues, and weight gain that emerge after stopping hormonal birth control. Elizabeth Katzman Website | https://strongchoices.com/ Instagram | https://www.instagram.com/strongchoices1/ TikTok | https://www.tiktok.com/@strongchoices Health Solutions Instagram | https://www.instagram.com/health_solutions_shawn_needham/ TikTok | https://www.tiktok.com/@healthsolutionspodcast Facebook | https://www.facebook.com/HealthSolutionsPodcast Moses Lake Professional Pharmacy Website | http://mlrx.com.com/ Facebook | https://www.facebook.com/MosesLakeProfessionalPharmacy/ Shawn Needham X | https://x.com/ShawnNeedham2 Shawn's Book | http://mybook.to/Sickened_The_Book Additional Links https://linktr.ee/mlrx

In this episode, I sit down with Rabbi Pill to explore the power of Mar Cheshvan and discover that it's not a spiritual lull at all, but the time when we're meant to integrate the inspiration of Tishrei into everyday life. We discuss how Jewish time moves in an upward spiral, and how Cheshvan shifts us from “gadlus ha'mochin” (expanded consciousness) to “katnus ha'mochin” (constricted consciousness), when serving Hashem without emotional highs becomes the real avodah. Drawing from Torah, Kabbalistic, and Chassidic sources, we reflect on how our service counts most when the excitement fades, and how the letter Nun—representing both falling and divine support—reminds us that every descent can become the beginning of an ascent. We also connect Cheshvan to the Flood and the dedication of the First Temple, showing how this same month can hold both darkness and revelation. On a practical level, we talk about yearning honestly for renewed connection, resisting the urge to escape discomfort, and carrying even one small piece of Tishrei forward—whether a mindful bracha or a focused moment in tefillah. The message is that Cheshvan invites us to bring Hashem into our work, family, and daily routine, turning quiet consistency into true transformation.Join the Conversation! Be part of our growing community—join the Shema Podcast for the Perplexed WhatsApp group to share feedback, discuss episodes, and suggest future topics. Click here to sign up.Get the Companion Guide: The Power of the MonthsThis free resource outlines the spiritual focus of each Hebrew month — including its mazal (zodiac sign), tribe, Hebrew letter, body part, and unique avodah. It also includes suggested actions you can take to align yourself with the energy of the time. Click here to download and keep this month-by-month guide as a tool for your own growth and reflection. 

Is your morning coffee secretly ruining your brain's energy? Discover the truth about optimizing your brain for more energy, better sleep, and improved focus in episode 825 of the Savage Perspective Podcast. Host Robert Sikes sits down with Dr. Patrick Porter to reveal how our modern lifestyle conflicts with our ancient biology and what you can do about it. They explore practical strategies for managing your cortisol, the real impact of blue light, and simple, effective habits to transform your daily routine and sleep quality for better overall wellness.Ready to pair a sharper mind with a stronger body? Join Robert's FREE Bodybuilding Masterclass and learn the methods to build an impressive physique. Sign up here: https://www.ketobodybuilding.com/registration-2Get Keto Brick: https://www.ketobrick.com/Subscribe to the podcast: https://open.spotify.com/show/42cjJssghqD01bdWBxRYEg?si=1XYKmPXmR4eKw2O9gGCEuQChapters:0:00 - The #1 Worst Thing You're Doing Every Morning 0:32 - How to Train Your Brain for More Energy 1:36 - Why Your Brain Isn't Built for the Modern World 2:32 - The Worst Foods for Your Brain (Is Your Breakfast on the List?) 3:13 - How to Biohack Your Brain with Sunlight 4:40 - The Tom Brady Rule for Maximum Recovery 5:53 - How Your Ancestors Are Still Influencing You 6:39 - The Real Reason You Get Sleepy at 2 PM 7:12 - How to Get a 4-Hour Nap in Just 20 Minutes 8:43 - The Secret to Beating Anyone's Sleep Score 9:31 - A Simple Breathing Trick to Unwind Your Mind 10:10 - The Shocking Truth About "Junk" DNA 11:33 - Proof That a Negative Mindset Makes You Sick 12:15 - The Perfect Morning Routine for Your Brain 14:17 - How to Maximize Your Workout Gains in 5 Minutes 16:13 - The Ultimate Post-Workout Recovery Stack 17:51 - Are You Wasting Your Food? How to Absorb More Nutrients 18:51 - Is Your Water "Dead"? The Truth About Structured Water 20:23 - The Science of "Good Vibes" (You're a Light Being) 22:38 - The Hidden Superpower You Already Possess 23:27 - The "Pill vs. Skill" Dilemma for True Health 25:22 - The Most Common Problem Found in 30,000 Brain Scans 26:54 - How Campfires Hypnotize Your Brain 28:54 - The Mental Health Crisis is a Physiological Problem 29:53 - The Truth About Blue Light Blocking Glasses 32:35 - How to Get Better Sleep (Expert Sleep Hacks) 33:01 - Why You're Getting Deep Sleep But NO REM Sleep 36:00 - How Much Sleep Do You Really Need? (It's Not 8 Hours) 38:35 - Why Alcohol is Pure Poison for Your Body 39:35 - Dr. Porter's Ultimate Sleep Hygiene Protocol 41:30 - How This Device Hacks Your Brainwaves 44:41 - The Science of Raising Your Brain's Voltage 46:51 - Why Most Binaural Beats on YouTube Don't Work 50:20 - The Surprising Effects of Psilocybin & Marijuana on the Brain 52:30 - Is Nicotine Actually GOOD for Your Brain? 54:07 - Where to Learn More About BrainTap 55:40 - Are People Focusing on the WRONG Things in Biohacking?

Beyond the Pill How Dr. Joseph Rosado Is Rewriting the Rules of Healing josephrosadomd.com In this compelling episode of THE EMBC NETWORK, host Hurricane H sits down with Dr. Joseph Rosado — emergency-room physician turned pioneering integrative health leader with more than 40 years of experience. From trauma medicine to being one of Florida's earliest advocates for medical cannabis and ketamine-assisted psychotherapy, Dr. Rosado is redefining what it means to heal. We explore how he blends science, compassion, and alternative therapies to address chronic pain, PTSD, treatment-resistant depression and more — offering hope when traditional medicine falls short. Whether you're a healthcare professional, someone seeking new paths to wellness, or simply curious about the future of healing, this conversation will challenge what you thought possible and invite you to imagine a whole-person approach to health.

Beyond the Pill How Dr. Joseph Rosado Is Rewriting the Rules of Healing josephrosadomd.com In this compelling episode of THE EMBC NETWORK, host Hurricane H sits down with Dr. Joseph Rosado — emergency-room physician turned pioneering integrative health leader with more than 40 years of experience. From trauma medicine to being one of Florida's earliest advocates for medical cannabis and ketamine-assisted psychotherapy, Dr. Rosado is redefining what it means to heal. We explore how he blends science, compassion, and alternative therapies to address chronic pain, PTSD, treatment-resistant depression and more — offering hope when traditional medicine falls short. Whether you're a healthcare professional, someone seeking new paths to wellness, or simply curious about the future of healing, this conversation will challenge what you thought possible and invite you to imagine a whole-person approach to health.

In Episode 325 You Will Discover: The role of working memory in an ADHD brain. What we mean by ADHD object permanence and how it shows up in our day to day. 3 Actionable ways to support our working memory with ease. Take the Free Quiz: What's Your Overwhelm Type? In under a minute, discover how overwhelm shows up for your ADHD brain — and what to do about it.

n the News.. COVID-19 & T1D, Ozempic Pill Progress, Faster Insulin, “Beyond Misconceptions,” and More It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: A new study looks at the link between COVID-19 and very young children, Lilly moves ahead with their Ozempic oral pill, ultra-rapid insulin clears another hurdle, Beyond Type 1 launches a new campaign and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX https://www.scientificamerican.com/article/advances-in-type-1-diabetes-science-and-tech/ This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. XX More evidence linking COVID 19 to type 1 diabetes.. but still exactly why is a mystery. During the COVID-19 pandemic, there was an unexpected increase in the number of cases of type 1 diabetes in Sweden, particularly among children under 5 and young adult men. The infection accelerated the onset of diabetes among children between the ages of 5 and 9. The researchers looked at data from a 17-year period on the incidence of type 1 diabetes among all people under the age of 30 in Sweden. In addition, they compared the risk of developing diabetes among 720,000 individuals with positive COVID-19 tests against a control group of 3.5 million people. The findings are published in the journal Diabetologia. The number of diabetes cases increased by 12% in 2021 and 9% in 2022 compared with previous years. In 2023, the number of cases was back to a normal level. Despite this, the researchers cannot distinguish a clear connection between COVID-19 infection and diabetes, except for children between 5 and 9 years old. They had an increased risk of type 1 diabetes about one month after a COVID-19 infection even though their total risk did not increase. "However, it's clear that the COVID-19 vaccine can be ruled out as a cause of the increase in diabetes cases. The recommendation for the age group where we saw the strongest increase was not to get vaccinated. In addition, other studies on adults have shown that vaccination reduces the risk of developing type 1 diabetes after a COVID infection." https://medicalxpress.com/news/2025-10-diabetes-young-people-pandemic.html XX A new gene therapy approach aimed at protecting people with type 1 diabetes from developing diabetic kidney disease—a serious and common complication of the condition, has shown promising results in a University of Bristol study. Findings from this new study, published in Molecular Therapy, demonstrated a 64% reduction in a damage indicator for kidney disease, paving the way for a potential new treatment. The study, explored the potential of delivering a protein called VEGF-C directly into kidney cells. Previous studies have shown VEGFC could protect against kidney disease as it helps keep blood vessels in the kidney filter healthy, repairing early signs of diabetes-related kidney damage. https://medicalxpress.com/news/2025-10-gene-therapy-kidney-disease-diabetes.html XX The FDA has agreed to consider Afrezza inhaled insulin for children and teens. The company said in August that it submitted a supplemental Biologics License Application (sBLA) for Afrezza in the pediatric population and it's been assigned a decision deadline date of the end of May, 2026. Afrezza first recieved FDA approval for adults (age 18 and up) in June 2014 https://www.drugdeliverybusiness.com/fda-accepts-application-mannkind-inhaled-insulin-kids/ Update on inhaled insulin for kids.. in the open-label, randomized, phase 3 INHALE-1 clinical trial Afrezza demonstrated safe and effective replacement for rapid-acting meal insulin in children with type 1 diabetes (T1D and demonstrates comparable glycemic control to injected rapid-acting insulin. The INHALE-1 clinical trial assessed the safety and efficacy of Afrezza among children and adolescents with T1D, including a total of 230 patients aged 4 to 17 years. Researchers used basal injected insulin and randomly assigned inhaled insulin or rapid-acting analogue for meals, evaluating the change in hemoglobin A1c levels at 26 weeks. After completing 26 weeks of randomly assigned treatment with either Afrezza or rapid-acting insulin injections combined with basal insulin, participants continued receiving the inhaled insulin until week 52 for an extension phase to evaluate the safety and effectiveness of Afrezza with continued use.1,2 https://www.pharmacytimes.com/view/inhaled-insulin-demonstrates-comparable-safety-lung-function-and-efficacy-to-injectable-insulin-in-type-1-diabetes XX Eli Lilly released the results of two new Phase 3 trials of an experimental GLP-1 pill that the company says could become a “foundational treatment” for type 2 diabetes. The Indianapolis-based drugmaker plans to submit global regulatory applications for orforglipron in the treatment of type 2 diabetes next year. The company said it will seek approval of the drug as an obesity medication by the end of 2025. Lilly is trying to build on the success of its Mounjaro/Zepbound franchise by offering patients a pill instead of an injection. But the company is trailing behind rival Novo Nordisk in developing an oral alternative, and data released so far has raised some skepticism among investors. A study released in August showed that orforglipron could help patients lose an average of about 12% of their body weight. Wall Street had been expecting more; Lilly's injectable drug Zepbound produced weight loss of as much as 21%, and Novo Nordisk has achieved 15% weight loss percentages for both oral and injectable versions of its Wegovy medication.   https://www.fiercebiotech.com/biotech/eli-lillys-orforglipron-bests-farxiga-padding-oral-glp-1-case-pair-phase-3-diabetes-wins   XX XX UF Health Cancer Center researchers have found a surprising culprit behind common health problems such as obesity, diabetes and fatty liver disease: silent genetic glitches in the blood system that occur naturally as people age. The findings, published in the Journal of Clinical Investigation, mean that in the future, simple blood tests could be developed to identify people most at risk early on, helping prevent chronic illnesses and cancer through strategies like diet or lifestyle changes. As people age, stem cells in the bone marrow that produce blood cells gradually accumulate mutations in their DNA. Most mutations don't cause any issues, but sometimes blood stem cells with a mutation can start crowding out their peers. Called clonal hematopoiesis, this condition affects about 10% of older people and is associated with an increased risk of blood cancers like leukemia. It's also linked to a higher risk of obesity and diabetes. But the prevailing thinking was that obesity and related conditions promoted blood cell changes, not the other way around. The new study reverses that. The implications could be far-reaching, particularly as obesity has now overtaken smoking as the most significant and preventable risk factor for cancer. The team is studying how the mutations drive disease. Next, they plan to test how drugs like those commonly used to treat diabetes and new popular weight loss drugs might help reverse or prevent diseases caused by blood cell changes. https://medicalxpress.com/news/2025-10-hidden-blood-mutations-obesity-diabetes.html XX A new ultra rapid insulin continues to move forward. A phase 3 clinical trial of BioChaperone Lispro (liss-pro) conducted in China found it safe and effective compared with Humalog along with a significant reduction of the rise of blood glucose after a test meal.     These results complete and confirm the positive outcomes previously obtained with THDB0206 injection in people with Type 2 Diabetes It combines Adocia's proprietary BioChaperone® technology with insulin lispro, the active ingredient in the standard of care, Humalog® (Eli Lilly).   This innovative formulation acts significantly faster https://pharmatimes.com/news/ultra-rapid-insulin-shows-promise-in-phase-3-trial-for-type-1-diabetes/   Poor blood sugar control in adolescent patients with type 1 diabetes (T1D) may be associated with a higher risk of neuropathy in adulthood, according to recent research from the University of Michigan.1 The study included children diagnosed with T1D between 1990-1992 who were recruited into the Cognition and Longitudinal Assessment of Risk Factors over 30 Years cohort study in Australia. Investigators collected HbA1c from medical records, and microvascular complications were assessed through self-reports, clinical screenings, retinal photographs, and urinary albumin-creatinine testing.3   A total of 30 children were recruited from the original cohort with a mean diagnosis age of 2.9 years. After an average of 29.7 years (standard deviation [SD]: 3.9 years), 33% of participants (n = 13) developed neuropathy, 63% (n = 19) developed diabetes-related eye disease, and 10% (n = 3) developed neuropathy.3 Mean HbA1c estimates during adolescence (9% [74.9 mmol/mol]; 95% CI, 8.6-9.3 [70.5-78.1]) were substantially higher than childhood (8.2% [66.1 mmol/mol]; 95% CI, 7.8-8.5 [61.7-69.4]; P

New friend Adam Ellwanger joins Sarah and Evan for a spicy episode of White Pill Radio. We look at Trump's recent comments on going to heaven, Salon talk vs. saloon talk, the Vatical rolling out the prayer carpets for Muslims, and a man accused of murder running for sheriff.

Know your testosterone from your progesterone? Dr Louise Newson, AKA The Menopause Doctor, joins Liz to help you better understand all of your hormones (not just oestrogen!)Inside this episode, Liz and Louise take a deep dive into the differences between synthetic and bio-indentical hormones.They discuss the current state of menopause care, and share where they would like to see it heading in the coming years.They also cover how hormones can benefit disease prevention and healthy ageing, not just your experience of menopause.Links mentioned in the episode:Follow Dr Louise Newson on InstagramDr Louise Newson websiteBalance MenopauseEverything You Need to Know About the Pill (but were too afraid to ask) by Kate MuirA Better Second Half by Liz EarleHave a question for Liz? Send a WhatsApp message or voicenote to 07518 471846, or email us at podcast@lizearlewellbeing.com for the chance to be featured on the showPlease note, on some occasions, we earn revenue if you click the links and buy the products, but we never allow this to bias our coverage and always honestly review. For more information please read our Affiliate Policy. Hosted on Acast. See acast.com/privacy for more information.

What does the Catholic Church teach about the use of contraception? Is there ever a time a woman can what is commonly called The Pill? What about Natural Family Planning, is this just Catholic birth control? Bishop Thomas John Paprocki has the answers.

European and US equity futures are lower across the board, with the US regional banking fears weighing on sentiment; KRE -2% in pre-market trade.DXY is a little lower; typical havens (JPY, CHF) benefit from the risk-tone whilst the Aussie lags.Global fixed paper driven higher as traders remain wary on US regional banks.Crude continues Thursday's selling, XAU choppy amid debt concerns.Looking ahead, Speakers including BoE's Pill, Greene & Breeden, Fed's Musalem, ECB's Nagel, Earnings from Ally Financial, SLB, American Express, State Street. Suspended Releases: US Building Permits/Housing Starts (Sep), Industrial Production (Sep).Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

US stocks were pressured with risk-off trade seen amid a reignition of regional banking woes after Western Alliance (WAL) and Zion Bancorp (ZION) announced exposure to bad loans tied to fraud, adding to the concerns following the collapse of Tricolor and First Brands.US KRE (Regional Banking ETF) closed lower by over 6% and the financial sector saw a near 3% hit, while the broad risk sentiment was hit with equities sliding throughout the US session.APAC stocks were predominantly lower as the region followed suit to the losses on Wall Street, where risk sentiment took a hit as regional bank concerns were reignited following loan fraud disclosures by Western Alliance and Zion Bancorp.European equity futures indicate a lower cash market open with Euro Stoxx 50 futures down 0.9% after the cash market closed with gains of 0.8% on Thursday.White House said regarding the Trump-Putin call that it was good and productive, while they have agreed to convene a meeting of high-level staff next week, which may then be followed by another Trump-Putin meeting.Looking ahead, highlights include EZ HICP Final (Sep), Atlanta Fed GDP, Suspended Releases: US Building Permits/Housing Starts (Sep), Industrial Production (Sep), Speakers including BoE's Pill, Greene & Breeden, Fed's Musalem, ECB's Nagel, Earnings from Ally Financial, SLB, American Express, State Street & Volvo AB.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

A new MP3 sermon from Answers in Genesis Ministries is now available on SermonAudio with the following details: Title: A Pill to Make You Moral? Subtitle: Answers with Ken Ham Speaker: Ken Ham Broadcaster: Answers in Genesis Ministries Event: Radio Broadcast Date: 10/14/2025 Length: 1 min.

We must appeal to an ultimate standard for morality—and we have one. The authority of the Word of God, given to us by our Creator.

We discuss Calvin Harris's hit "Feels" featuring Katy Perry, Pharrell, and Big Sean, and the casual pill popping culture it reflects.And we discuss the etymology of pill, the history of pills, and the modern rise of being pilled - red-pilled, black-pilled, and ______-pilled, in which someone can be anything-pilled, describing a thing that they've recently gotten into or come around to.Find us on instagram here: https://www.instagram.com/gettingdownandwordy/And email us at gettingdownandwordy@gmail.comHuge thanks to Patsy Walker for the use of our theme song “Who's Wordy Now”!This week's promoted podcast is Speak of the Devil. Find them anywhere you get podcasts or at this link: https://linktr.ee/speakofthedevilFind them, us, and lots of other great podcasts on our podcast network podmoth.network

Charlie Kirk assassination - New information from Candace Owens suggests Charlie was shot from the front with a small-caliber round. We have questions about this. "President of Peace" - let's discuss the wartime efforts of President Trump, who has initiated efforts on a plethora of fronts over the last 10 months, INCLUDING AUTHORIZING THE USE OF WHITE PHOSPHORUS IN GAZA! UNBELIVEABLE: Video coming out of Ukraine - is "New Khazaria" a "fringe conspiracy theory"? PLEASE SUPPORT THE STEW PETERS NETWORK! $9 per month unlocks ALL historical archives, grants early access to documentary films, "OFF-THE-RECORD" segments with Stew and 24/7 Live chat! https://stewpeters.tv

Ben Maller talks about why things have gone so badly for Bill Belichick at North Carolina, reports that UNC is digging into rule violations under Belichick, what happens next as Belichick prepares to leave North Carolina, Fact or Fiction, and more!See omnystudio.com/listener for privacy information.

It's Thursday, October 9th, A.D. 2025. This is The Worldview in 5 Minutes heard on 140 radio stations and at www.TheWorldview.com.  I'm Adam McManus. (Adam@TheWorldview.com) By Jonathan Clark Pakistani pastor dies after 13-year jail sentence A pastor in Pakistan died on Sunday after languishing in prison for 13 years. Pastor Zafar Bhatti founded Jesus World Mission Church ministry. Back in 2012, he was falsely accused of insulting Islam. Authorities finally overturned his conviction this month, releasing him last Wednesday. The 62-year-old pastor died days after from cardiac arrest at his home.   The British Asian Christian Association helped defend the pastor in court. The organization stated, “Though his earthly journey has ended, Zafar's faith, endurance, and ultimate vindication remain a powerful testament to hope in Christ amidst persecution.” Nigerian Anglican Church appalled that woman chosen to be new church head The Anglican Church of Nigeria declared spiritual independence from the Church of England on Tuesday. The announcement came in response to the Church of England's appointment of Sarah Mullally as the Archbishop of Canterbury. She is the first woman to hold the position. She also supports abortion and faux homosexual marriage.  Archbishop Henry Ndukuba is the Primate of the Church of Nigeria. He stated, “[Mullally's] appointment marks a tragic departure from biblical orthodoxy. . . . We remain Anglicans — but not under Canterbury. Our loyalty is to Christ and the truth of His Word, not to institutions that have abandoned it.” Police arrest man intent on blowing up church with Supreme Court Justices In the United States, police arrested a man on Sunday who had hundreds of explosive devises outside of St. Matthews Cathedral in Washington, D.C. Police made the arrest before an annual service traditionally attended by U.S. Supreme Court justices.  According to court records, the man's notebook expressed animosity toward Supreme Court justices, the Catholic Church, Jews, and immigration enforcement officials.  FBI cuts ties with God-hating Southern Poverty Law Center The Federal Bureau of Investigation announced last week it has cut ties with the Southern Poverty Law Center. The far-left nonprofit is known for listing conservative and Christian organizations as “hate groups,”  primarily because they affirm God's design for sexuality and marriage. FBI Director Kash Patel posted on X, “The Southern Poverty Law Center long ago abandoned civil rights work and turned into a partisan smear machine. Their so-called ‘hate map' has been used to defame mainstream Americans and even inspired violence. That disgraceful record makes them unfit for any FBI partnership.” Florida, Louisiana, Missouri & Texas sue FDA over mail-order Abortion Kill Pill The state of Louisiana joined a lawsuit against the Food and Drug Administration on Monday.  Florida, Missouri, and Texas are also on the case. They are challenging the FDA's 2023 policy that allows mail-order abortion drugs. Louisiana's filing states, “Every year, doctors and activists in states like California and New York mail a U.S. Food and Drug Administration (FDA)-approved abortion drug called mifepristone to thousands of Louisiana residents for the express purpose of causing abortions in Louisiana that are blatantly unlawful.” Gold hit $4,000 per ounce first time ever On Tuesday, spot gold prices hit $4,000 per ounce for the first time in history.  That's up 50% from January. Silver is up 60% this year. The demand for gold is up as investors hedge against economic uncertainty.  Financial analyst Rhona O'Connell told Reuters, “Background factors are much the same as before, in terms of geopolitical uncertainty, with the added spice of the (U.S.) government shutdown.” Prison Fellowship and Bible League to send 620,000 Bibles to prisoners And finally, Prison Fellowship International and Bible League International are partnering to distribute over half a million Bibles. The 620,000 Bibles will go to prisoners in 20 countries over the next five years. Frank Lofaro with Prison Fellowship International said, “God's Word has the power to reach prisoners in their darkest moments with the light of Jesus Christ. Through this partnership, prisoners who come to know Jesus through our evidence-based, in-prison programs are equipped to grow in their faith through a Bible that they can understand and that speaks to their circumstances.” Luke 4:18 says, “The Spirit of the LORD is upon Me, because He has anointed Me to preach the gospel to the poor; He has sent Me to heal the brokenhearted, to proclaim liberty to the captives and recovery of sight to the blind, to set at liberty those who are oppressed.” Close And that's The Worldview on this Thursday, October 9th, in the year of our Lord 2025. Follow us on X or subscribe for free by Spotify, Amazon Music, or by iTunes or email to our unique Christian newscast at www.TheWorldview.com.  I'm Adam McManus (Adam@TheWorldview.com). Seize the day for Jesus Christ.

01. Josh Baker, The Egyptian Lover, Rome Fortune - Dr Feel Right 02. Byor - You're So Awesome! 03. Ilkay Sencan, Tima Dee - Money Don't Sleep 04. Hawk, Azooland - Pleasure 05. Clean Bandit, Anne-Marie, David Guetta - Cry Baby (VIP Mix) 06. Bob Sinclar, Nyv - Drama on the Dancefloor 07. The Chemical Brothers, Chris Lake - Galvanize 08. Sam Shelby - Thunder 09. Luciana, James Hurr - Queen I'm In Charge 10. Dj Zinc, Ms Dynamite - Wile Out 24 11. Mike Williams, Firebeatz - Womp 12. Fedde Le Grand - Got Your Money 13. Damon Sharpe - Housaholic 14. Don Kon - Calling 15. Sonny Fodera, D.O.D - Somedays 16. Cassimm, Pietro, Mc Panda - Vem Pra Rave 17. Arty, Nu-La - Flames 18. Mitch B., Yvvan Back, Zen - Ring My Bell 19. Bakermat - Wahejo 20. Cid - Pass Out 21. Joxion - Say Less 22. Steve Angello - Hooligans 23. Kush Kush, Sofiya Nzau - Higher Love 24. Sick Individuals, Martin Jasper - Dreamer (Just Like You) 25. Dannic - All Mine 26. Will K - Lick It 27. Darius Syrossian, Kathy Brown - Work It Out 28. Soultight - Dum 29. Ruzz - PUSH 30. Tv Noise - Love Up High 31. Martin Ikin - Back In Time 32. Mike Posner, Steve Aoki - I Took a Pill in Ibiza 33. Vintage Culture, Noah Kulaga - Upon Your Skin 34. Don Diablo - Lose Control 35. Ownboss, Subb - Dooms Night 36. Argy, Eli & Dani, Peki Ofc, Osher - Chasing Highs 37. Nightlapse, Emilie Rachel - Breaks 38. Alok, Artbat - Truth, Peace, Love, Acid

From hot flushes to brain fog. Hormones to headaches. Ask us anything. We’ve got you covered. In this episode, Dr Mariam and Claire Murphy tackle your most pressing questions about the menopausal transition. They begin by reframing this stage of life and looking at how other cultures (even some of the animal kingdom) view post-reproductive years as a time of renewal, leadership, wisdom and strength. They talk to the experts to answer questions about whether it's ever too late to start MHT, if those hot flushes in your 30s could be a sign of perimenopause, and what to do if you’re worried your brain fog is actually dementia. They also discuss peri-anxiety. Why you might be losing your hair in your 40s. And, what is the correct way to apply estrogen gel? Plus, can you still get pregnant during perimenopause, and is MHT the same as birth control? THE END BITS All your health information is in the Well Hub. For information on brain fog, Dr Sonia Davison recommends Memory Wise by Dr Anne Unkenstein. For information on patterned hair loss she recommends the Better Health Channel patterned hair loss information sheet. For more information on perimenopause and menopause, navigate to the Australasian Menopausal Society, the Endocrine Society, the International Menopause Society and Jean Hailes For Women’s Health. GET IN TOUCH Sign up to the Well Newsletter to receive your weekly dose of trusted health expertise without the medical jargon. Ask a question of our experts or share your story, feedback, or dilemma - you can send it anonymously here, email here or leave us a voice note here. Ask The Doc: Ask us a question in The Waiting Room. Follow us on Instagram and Tiktok. Support independent women’s media by becoming a Mamamia subscriber CREDITS Hosts: Claire Murphy and Dr Mariam Guests: Dr Sonia Davison; Professor Rodney Baber Senior Producers: Claire Murphy and Sally Best Audio Producer: Scott Stronach Video Producer: Julian Rosario Social Producer: Elly Moore Mamamia acknowledges the Traditional Owners of the Land we have recorded this podcast on, the Gadigal people of the Eora Nation. We pay our respects to their Elders past and present, and extend that respect to all Aboriginal and Torres Strait Islander cultures.Information discussed in Well. is for education purposes only and is not intended to provide professional medical advice. Listeners should seek their own medical advice, specific to their circumstances, from their treating doctor or health care professional. +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++Support the show: https://www.mamamia.com.au/mplus/See omnystudio.com/listener for privacy information.

EU sees new US trade demands hollowing out deal struck by US President Trump, according to Bloomberg citing sources.European bourses are broadly firmer but with ASML (-1.7%) weighing on the AEX; US equity futures are modestly higher.USD continues to rally, boosted by a weak JPY and NZD; the Kiwi is the clear underperformer after the RBNZ delivered a jumbo 50bps cut and left the door open for more rate reductions.Global paper moves higher, OATs outperform, awaiting French PM Lecornu later.XAU topped the USD 4,000/oz mark, crude is continuing to rebound as China is set to re-enter the market tomorrow.Looking ahead, NBP Policy Announcements, FOMC Minutes (Sep), Speakers including BoE's Pill, ECB's Elderson & Lagarde, Fed's Musalem, Barr, Goolsbee & Kashkari, NVIDIA CEO Huang, French PM Lecornu, Supply from US.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

APAC stocks trade mixed with demand hampered following the negative handover from the US; European futures flat.RBNZ cut rates by 50bps and kept the door open to further rate cuts.US President Trump said a lot of things will be eliminated due to the shutdown, and he will tell us about the eliminated jobs in four or five days.USD remains on the front foot, NZD lags post-RBNZ, JPY digests soft real cash earnings data.Spot gold continued its advances, in which spot prices climbed above the USD 4,000/oz level.Looking ahead, highlights include German Industrial Output (Aug), Swedish CPIF Flash (Sep), NBP Policy Announcements, FOMC Minutes (Sep), BoE's Pill, ECB's Elderson & Lagarde, Fed's Musalem, Barr, Goolsbee & Kashkari, Supply from UK, Germany & US.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

Should you train for how you look, or how long you live? We're unpacking the research on BMI vs muscle for longevity, the body image tug-of-war many women face when it comes to aesthetics in fitness, and how to know if you need a deload week. Plus, we cover the surprising nutrient depletions that can happen with medications like birth control and SSRIs.Timestamps:[1:50] Welcome[3:13] Study whether muscle mass index helps you actually lives longer[10:08] I sometimes struggle to balance the aesthetic side of strength training (wanting to look fit) and the longevity side of strength training (wanting to be healthy). How do you both think about strength training as women in a culture that pushes us towards body ideals and how can we shift our motivation so it's less about appearance and more about health and independence long -term? [22:24] Can you talk about deload weeks vs rest weeks? How do you manage mindset and guilt? Can you discuss nutrient depletion around medications and should you supplement? [40:15] Do I need to incorporate heavy weights in my workout to set myself up for my goals in old age? Episode Links:Article: Muscle Mass Index as a Predictor of Longevity in Older-AdultsEpisode #213: The Pill, Irregular Periods, & Post-Birth Control Syndrome with Dr. Jolene Brighten Beyond the PillSponsors:Go to http://mdlogichealth.com/whey-protein, and use coupon code WELLFED for 10% off.Go to drinklmnt.com/wellfed and use code WELLFED to get a free 8-pack with any drink mix purchase!Go to coconutsandkettlebells.com/air and click the link in the review for $300 off select models and 10% off filters. 

It's Tuesday, October 7, A.D. 2025. This is The Worldview in 5 Minutes heard on 140 radio stations and at www.TheWorldview.com.  I'm Adam McManus. (Adam@TheWorldview.com) By Kevin Swanson Nigerian military opened fire on Christians Christian persecution at the hands of Muslim terrorists in Nigeria was tough enough. Now, Truth Nigeria reports that the Nigerian military has opened fire on Christians in the Benue State — this time killing three young men. Ten others sustained life-threatening gunshot wounds and are receiving medical treatment in Jato-Aka. The local chief said, “We no longer need the military in our land. … They have joined Fulani to kill us and take over our land. They have turned their guns against us. … The betrayal is unbearable. Enough is enough. President Tinubu and Governor Alia should hear this message and take immediate action.” Newsweek urges State Dept to declare Nigeria “Country of Particular Concern” Newsweek.com has joined the voices of comedian Bill Maher and others, pointing to the egregious level of Christian killings in Nigeria. The Nigerian government has “categorically” denied that terrorists are waging a systematic genocide against Christians in the country. Newsweek noted that the Trump State Department has thus far failed at making Nigeria a “Country of Particular Concern.” Europe's swirling politics France just lost its third prime minister in about a year. Sébastien Lecornu was the latest, and he just resigned yesterday after only 27 days in office. This marks the most instability for the French government in 70 years. France's nationalist, anti-immigration party increased from obtaining 4% of parliamentarian seats in 2008 to 37% in 2024. Germany lost its government earlier this year.  Germany's anti-immigration party is supported by 24% of the country, up from virtually nothing ten years ago.  And Portugal faces instability, still run by a minority government, having completed its third election in three years in May.  Portugal's nationalist party increased from half percent in 2019 to 23% in the 2025 elections. Also, the Netherlands, Sweden, Finland, and Italy have experienced wide swings in governance — shifting to a nationalist position over the last 5-10 years. Daniel 2:21 reminds us that it is God who “changes times and seasons; He removes kings and sets up kings; He gives wisdom to the wise and knowledge to those who have understanding.” Cuba sends 5,000 troops to aid Ukraine despite grinding poverty Reuters reports that Cuba is supporting the Ukrainian War now with up to 5,000 troops. The communist country's economy is lagging badly — suffering a four-year decline in its Gross Domestic Product, with another decline forecasted for this year, reports InDepthNews.com. Inflation is running at 28%. The nation has suffered at least five energy blackouts this year so far.  And 89% of the populace suffers from “extreme poverty” according to a recent survey. Seven out of ten Cubans have stopped eating breakfast, lunch, or dinner due to lack of money or food shortages. Only 15% have been able to eat three meals a day without interruption. That compares with the next poorest countries in Central America. Just 16% of Guatemalans  and 27% of folks in Honduras have to deal with these levels of extreme poverty. Supremes consider Trump's tariffs, Hawaii's gun restrictions, &  trans sports As the US Supreme Court reconvenes, the docket holds a slew of cases. They include the legitimacy of the Trump Tariffs, the president's removal of high level administrative bureaucrats, Colorado's ban on counselors helping minors out of homosexual sin, Hawaii's gun restrictions, and bans issued by red states on boys pretending to be girls playing in girls' sports in public schools.  Trump's FDA approve a new Abortion Kill Pill The Trump Administration's Food and Drug Administration approved another abortion kill pill to accommodate the killing of children in their mother's wombs. Last week, the FDA approved Evita Solutions' generic abortion drug for the US market. This is hardly in line with the administration's pledge to “review all the evidence—including real-world outcomes—on the safety of the drug” issued just last month. Ostensibly, the big concern is the health of the mother. The FDA reports 36 deaths attributed to the abortion kill pill thus far, but 7.5 million murdered babies. 63% of the annual abortions committed in the country today are attributed to the abortion kill pill.  Isaiah 29:15-16 speaks to this. The prophet wrote, “Woe to you who hide deep from the Lord your counsel, whose deeds are in the dark, and who say, “Who sees us? Who knows us?” You turn things upside down! Shall the potter be regarded as the clay, that the thing made should say of its maker,  “He did not make me”; or the thing formed say of him who formed it, “He has no understanding”? Mt. Everest hiker died, 200 others stranded in shock blizzard And finally, one hiker has died and 200 others are still stranded in a shock blizzard on Mount Everest over the weekend. The blizzard took about 1,000 hikers by surprise.  Thus far this year, five people have died on Everest. Last year's total was eight, and 18 others died on the treacherous slopes in 2023. About 800 people attempt to summit the tallest mountain in the world each year. Close And that's The Worldview on this Tuesday, October 7th, in the year of our Lord 2025. Follow us on X or subscribe for free by Spotify, Amazon Music, or by iTunes or email to our unique Christian newscast at www.TheWorldview.com.  I'm Adam McManus (Adam@TheWorldview.com). Seize the day for Jesus Christ.

Happy Q4 Heart of Healthcare Listeners! We're back with your monthly Digital Health Download, where we discuss the biggest industry headlines of the month. We cover:

For H-Hour perks, join the H-Hour Discord guild: https://discord.com/invite/KCb54MQNxd and follow H-Hour Hugh on X: https://x.com/HughKeir Tina Woods joins H-Hour to share her profound journey from studying genetics to revolutionizing the health and well-being sector. This episode explores her innovative approach to combining science and rave culture through co-founding Longevity Rave, the impact of the Human Exposome Project, and the role of social behaviour in achieving a healthier life. Tina discusses the transformative effects of technology on health, the significance of community, and the critical importance of preventative care over the traditional healthcare model. Join us for a conversation filled with insights on human flourishing, longevity, and breaking boundaries in the health industry. https://longevityrave.world https://www.instagram.com/longevity.rave https://soundcloud.com/user-639532491

What happens when you choose a normal birth with twins?In this episode, I speak with Nicole, a mother from South Africa now living in the U.S., who chose sovereignty in one of the most medicalized and “high-risk” experiences imaginable: an identical twin pregnancy. From the very beginning, she was met with fear-based narratives—warnings of stillbirth, premature labor, and twin-to-twin transfusion syndrome. But after enduring traumatic experiences in hospitals and with midwives, Nicole knew she would not birth her twins within the system.Instead, she underwent a profound process of deconditioning and committed to trusting her body. With the steady support of her husband, a Radical Birth Keeper graduate, and a community of women walking this same path, Nicole carried her twins to 40 weeks and welcomed them at home, in embodied sovereignty.Nicole shares the raw reality of holding responsibility for twins outside the system: the constant conversations about risk, the deep conviction it took to turn away completely, and the profound freedom of reclaiming birth on her own terms.Inside this episode:What Nicole witnessed in the hospital that made her vow never to returnHow she carried her twins to full term, trusting her body's wisdomThe support she found in a community of sovereign mothersWhat labor with twins looked like at homeThe double standard of blame when outcomes differ at home versus in the hospitalThe freedom and healing that come with birthing twins in sovereigntyTimestamps:[00:00] Introduction[02:59] Two miscarriages and lack of support and answers from the medical system[07:05] Receiving news of a third unviable pregnancy and deciding not to take the pill[09:02] Discovering that the medical system was wrong about her third pregnancy, and that her baby was alive and healthy in her womb[11:19] Birthing her first son in a birthing center with a midwife, forced interventions, a fourth degree tear, and newborn separation[21:36] Postpartum hospital trauma, overreactions and threats[25:15] Another miscarriage and humiliating hospital treatment[32:13] Finding out she was pregnant with twins, midwife refusing to provide care, and choosing freebirth[1:00:00] Freebirthing her twins at home with her husband and birth attendant presentIf you want to connect more with Nicole, follow her on Instagram.Find more from Emilee on Instagram, YouTube and the Free Birth Society website.Disclaimer: Free Birth Society, LLC of North Carolina shares personal and educational stories and experiences related to freebirth and holistic care. This content is not medical advice, and we are not a licensed midwifery practice. Testimonials reflect individual experiences; results may vary. For services or scheduling, contact info@freebirthsociety.com. See full disclaimer at freebirthsociety.com/youtubeterms.

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: Sanofi lowers prices, oral pill for T1D prevention studied, updates from Medtronic, Tandem, and Sequel Med Tech, falsely lower A1Cs (and why that happens), Biolinq gets FDA okay for micro-needle CGM and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX French drugmaker Sanofi says it would offer a month's supply of any of its insulin products for $35 to all patients in the U.S. with a valid prescription, regardless of insurance status. The program, originally meant for uninsured diabetes patients, would now include those with commercial insurance or Medicare, the drugmaker said. Patients will be able to purchase any combination, type, and quantity of Sanofi insulins with a valid prescription for the fixed monthly price of $35, starting January 1. Lilly and Novo also have similar programs through which they offer insulin products for $35 a month for U.S. patients regardless of whether the patients have insurance. There is no law at work here – the only legislation that has changed the price of insulin came with the Inflation Reduction Act in 2022 with the Medicare cap. Helping lower the cost here, biosimilars hitting the market and the huge profitability for GLP-1 drugs for Novo and Lilly https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-offer-all-insulin-products-35-per-month-us-2025-09-26/ XX A pill typically prescribed for rheumatoid arthritis and alopecia might help slow the progression of type 1 diabetes, a new study says. Baricitinib (bare-uh-SIT-nib) safely preserved the body's own insulin production in people newly diagnosed with type 1 diabetes.. and their diabetes started progressing once they stopped taking baricitinib, results show. They produced less insulin and had less stable blood sugar levels.   Baricitinib works by quelling signals in the body that spur on the immune system, and is already approved for treating autoimmune conditions such as rheumatoid arthritis, ulcerative colitis and alopecia, researchers said.   “Among the promising agents shown to preserve beta cell function in type 1 diabetes, baricitinib stands out because it can be taken orally, is well tolerated, including by young children, and is clearly efficacious,” Waibel said. “We are hopeful that larger phase III trials with baricitinib are going to commence soon, in people with recently diagnosed type 1 diabetes as well as in earlier stages to delay insulin dependence,” she added. “If these trials are successful, the drug could be approved for type 1 diabetes treatment within five years.”   Findings presented at medical meetings should be considered preliminary until published in a peer-reviewed journal.   https://www.usnews.com/news/health-news/articles/2025-09-23/pill-effective-in-slowing-type-1-diabetes-progression XX An existing transplant drug has shown promise in slowing the progression of type 1 diabetes in newly diagnosed young people, potentially paving the way for the first therapy that modifies the disease after diagnosis. The Drug, called ATG, is currently used together with other medicines to prevent and treat the body from rejecting a kidney transplant. It can also be used to treat rejection following transplantation of other organs, such as hearts, gastrointestinal organs, or lungs. The researchers studied 117 people aged five to 25, who'd been diagnosed with type 1 diabetes within the past three to nine weeks. The participants were from 14 centers across eight European countries and were randomized to be given different doses of ATG (0.1, 0.5, 1.5, or 2.5 mg/kg) or a placebo. ATG was given as a two-day intravenous (IV) infusion. The main goal was to see how well the pancreas could still make insulin after 12 months, measured by C-peptide levels during a special meal test. C-peptide is released into the blood along with insulin by the pancreas.   The findings are promising, showing that ATG, even at a relatively low dose, can slow the loss of insulin-producing cells in young people newly diagnosed with type 1 diabetes. The lower dose also caused fewer side effects, making it a more practical option. https://newatlas.com/disease/antithymocyte-globulin-newly-diagnosed-type-1-diabetes/     XX The FDA has delayed its feedback on Lexicon Pharmaceuticals' application to bring Zynquista (sotagliflozin) to people with type 1 diabetes. The agency had planned to respond this month but will now wait until the fourth quarter after reviewing new data from ongoing studies. Zynquista, an oral drug meant to be used with insulin, has already been approved for heart failure (marketed as Inpefa). But in type 1 diabetes, it faces safety concerns: last year an FDA advisory committee voted 11–3 that its benefits don't outweigh the increased risk of diabetic ketoacidosis (DKA). The FDA later issued a complete response letter rejecting the drug. Lexicon is still pushing forward, hoping its additional submissions will strengthen Zynquista's case for type 1 diabetes approval. https://www.biospace.com/fda/after-fda-rejection-lexicons-type-1-diabetes-drug-hit-with-another-regulatory-delay     XX A common but often undiagnosed genetic condition may be causing delays in type 2 diabetes diagnoses and increasing the risk of serious complications for thousands of Black and South Asian men in the UK—and potentially millions worldwide. A new study found around one in seven Black and one in 63 South Asian men in the UK carry a genetic variant known as G6PD deficiency. Men with G6PD deficiency are, on average, diagnosed with type 2 diabetes four years later than those without the gene variant. But despite this, fewer than one in 50 have been diagnosed with the condition.   G6PD deficiency does not cause diabetes, but it makes the widely used HbA1c blood test—which diagnoses and monitors diabetes—appear artificially low. This can mislead doctors and patients, resulting in delayed diabetes diagnosis and treatment.   The study found men with G6PD deficiency are at a 37% higher risk of developing diabetes-related microvascular complications, such as eye, kidney, and nerve damage, compared to other men with diabetes.   "This study highlights important evidence that must be used to tackle these health inequalities and improve outcomes for Black communities. Preventative measures are now needed to ensure that Black people, especially men, are not underdiagnosed or diagnosed too late." https://medicalxpress.com/news/2025-09-hidden-genetic-delay-diabetes-diagnosis.html XX Novo Nordisk today announced the resubmission of its Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for Awiqli® (insulin icodec) injection, a once-weekly basal insulin treatment for adults living with type 2 diabetes. If approved, Awiqli® would become the first once-weekly basal insulin available in the United States, providing an alternative to daily basal insulin injections for adults living with type 2 diabetes.   The resubmission is based on results from the ONWARDS type 2 diabetes phase 3a program for once-weekly Awiqli® which is comprised of five randomized, active-controlled, treat-to-target clinical trials in approximately 4,000 adults with type 2 diabetes. The clinical program evaluated Awiqli® vs. daily basal insulin and the primary endpoint in these trials was change in A1C from baseline.1-5 Awiqli® is approved in the EU, along with 12 additional countries. In addition, regulatory filings have been completed in several other countries, with further regulatory decisions expected in 2025. XX Interesting news from Sequel Med Tech – they've signed an agreement with Arecor to pair the twiist pump with AT278 an ultra-concentrated (500U/mL), ultra-rapid insulin in development. They also have a deal with Medtronic to develop insulin for new pumps. This insulin isn't yet approved, it's 5 times stronger than standard fast acting  it's hoped that a clinical study will begin next year. Arecor says its insulin could potentially be the only option capable of enabling and catalyzing the next generation of longer-wear and miniaturized automated insulin delivery systems.   https://www.drugdeliverybusiness.com/sequel-arecor-develop-rapid-insulin-twiist/ XX Tandem Diabetes Care announes its t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID) technology is now cleared for use with Eli Lilly and Company's Lyumjev® (insulin lispro-aabc injection) ultra-rapid acting insulin in the United States (U.S.).   – The t:slim X2 insulin pump with Control-IQ+ technology is now cleared for use with Lyumjev for people with type 1 diabetes ages 2 and above and all adults with type 2 diabetes. The companies are continuing to work toward securing Lyumjev compatibility for the Tandem Mobi pump. https://hitconsultant.net/2025/09/29/tandem-diabetes-cares-tslim-x2-pump-cleared-for-use-with-lillys-ultra-rapid-lyumjev-insulin/ XX You can now place your order for the MiniMed™ 780G system with the Instinct sensor, made by Abbott. And if you are already a MiniMed 780G user, you can place an upgrade order today. ​This is a 15 day wear sensor, with no transmitter or overtape required. It looks the same at other Abbot sensors such as the Libre but is proprietary to Medtronic. Shipments are scheduled to start in November.   ​ https://www.drugdeliverybusiness.com/medtronic-launches-minimed-780g-instinct-abbott/   XX The global type 1 diabetes (T1D) burden continues to increase rapidly driven by rising cases, ageing populations, improved diagnosis and falling death rates. ,   The study estimates that T1D will affect 9.5 million people globally in 2025 (up by 13% since 2021), and this number is predicted to rise to 14.7 million in 2040. However, due to lack of diagnosis and challenges in collecting sufficient data, the actual number of individuals living with T1D is likely much higher, researchers say.   In fact, they estimate that there are an additional 4.1 million 'missing people' who would have been alive in 2025 if they hadn't died prematurely from poor T1D care, including an estimated 669,000 who were not diagnosed. This is particularly true in India, where an estimated 159,000 people thought to have died from missed diagnoses. The study predicts that 513,000 new cases of T1D will be diagnosed worldwide in 2025, of which 43% (222,000) will be people younger than 20 years old. Finland is projected to have the highest incidence of T1D in children aged 0-14 years in 2025 at around 64 cases per 100,000. The substantial increases in T1D forecasts between 2025 and 2040 underscore the urgent need for action. As co-author Renza Scibilia from Breakthrough T1D explains, "Early diagnosis, access to insulin and diabetes supplies, and proper healthcare can bring enormous benefits, with the potential to save millions of lives in the coming decades by ensuring universal access to insulin and improving the rate of diagnosis in all countries."   The authors note some important limitations to their estimates, including that while the analysis uses the best available data, predictions are constrained by the lack of accurate data in most countries-highlighting the urgent need for increased surveillance and research. They also note that data on misdiagnosis and adult populations remain limited, and the analysis assumes constant age-specific incidence and mortality over time. Furthermore, incidence data from the COVID-19 period were excluded from part of the modelling to avoid bias. Future updates are expected to improve as new data become available and applied. https://www.news-medical.net/news/20250919/New-study-warns-of-millions-of-undiagnosed-and-missing-people-with-type-1-diabetes.aspx XX A new study has found that semaglutide — the active ingredient found in some GLP-1 medications prescribed for diabetes and to aid weight loss — may help protect the eyes from diabetic retinopathy. Researchers estimate that as much as 40% of all people with diabetes also have diabetic retinopathy — a potentially blinding eye condition caused by blood vessel damage in the eye's retina. There is currently no cure for diabetic retinopathy. The condition is often managed through injections of anti-VEGF medications into the eye, surgery, and blood sugar monitoring and control. For this lab-based study, researchers used samples of human retinal endothelial cells that were treated with different concentrations of semaglutide. The cells were then placed in a solution with both a high glucose level and high level of oxidative stress — where there is an imbalance of antioxidants and free radicals — for 24 hours.   Past studies show that oxidative stress plays a role in the formation of diabetic retinopathy.   At the study's conclusion, researchers found that the retinal cells treated with semaglutide were twice as likely to survive than cells that were untreated. Additionally, the treated cells were found to have larger stores of energy.   Scientists also found that three markers of diabetic retinopathy were decreased in the semaglutide-treated retinal cells. First, the levels of apoptosis — a form of cell death — decreased from about 50% in untreated cells to about 10% in semaglutide-treated cells. The production of the free radical mitochondrial superoxide decreased from about 90% to about 10% in the treated retinal cells.   Researchers also found the amount of advanced glycation end-products — harmful compounds that can collect in people with diabetes and are known to cause oxidative stress — also decreased substantially.   Lastly, scientists reported that the genes involved in the production of antioxidants were more active in the semaglutide-treated cells when compared to untreated cells. Researchers believe this is a sign that semaglutide may help repair damage to the retinal cells.   “Our study did not find that these drugs harmed the retinal cells in any way — instead, it suggests that GLP1-receptor agonists protect against diabetic retinopathy, particularly in the early stages,” Ioanna Anastasiou, PhD, molecular biologist and postdoctoral researcher at the National and Kapodistrian University in Greece, and lead author of this study, said in a press release.   “Excitingly, these drugs may be able to repair damage that has already been done and so improve sight. Clinical trials are now needed to confirm these protective effects in patients and explore whether GLP-1 receptor agonists can slow, or even halt, the progression of this vision-robbing condition.” https://www.medicalnewstoday.com/articles/ozempic-semaglutide-may-help-protect-against-diabetes-related-blindness-retinopathy   XX Biolinq has received De Novo Classification from the U.S. Food and Drug Administration for its lead product, Biolinq Shine, a patch on the forearm that provides real-time glucose feedback through a primary color-coded LED display, visible with or without a phone. This one is tricky – it's called a needle free CGM but it also says it uses micro needles. By the way, De Novo isn't exactly the same as what we think of for FDA approval for medical devices. It's not as rigorous but it's a streamlined route for novel, low to moderate risk devices with no existing equivalent. We'll see how this one turns out. https://www.hmenews.com/article/biolinq-s-multi-function-biosensor-receives-fda-de-novo-classification

Quite possibly no invention in modern history has done more to change women's lives than the pill so important it can just be called: The Pill. Safe, reliable, relatively easy birth control was a game changer for many (but not all) women. Visit the ⁠website⁠ (herhalfofhistory.com) for sources, transcripts, and pictures. Support the show on my ⁠Patreon page⁠ for bonus episodes, polls, and a general feeling of self-satisfaction. Or make a one-time donation on ⁠Buy⁠ ⁠Me a Coffee⁠. Join ⁠Into History⁠ for a community of ad-free history podcasts plus bonus content. Visit ⁠Evergreen Podcasts⁠ to listen to more great shows. Follow me on ⁠Threads⁠ as Her Half of History. Learn more about your ad choices. Visit megaphone.fm/adchoices

Oscar, Sarah, and Evan look at some weak-sauce comments by the pope on the pro-life position, several Charlie Kirk articles including whether witchcraft works and a pastor who says Charlie was "unChristlike," and an article by Evan on Substack about ways to limit Muslim influence...if that is a thing the West ever wants to do.

Seven home-and-away weeks down, five more to go - the AFLW season's going OFF and we're very lucky to have Hester Brown on board to help us break it down. There's stacks on the show this week. Six-year-old podcasting extraordinaire Aila Brown comes out swinging with her Hot Take of the Week, and Broden and Tom provide a roving report from the Olympia Theatre, Dublin. Chappell Roan played there once. With feeling folks, no matter what the Big House says: BOUNCE. THAT. PILL. Get around Hester here.

Today, I am thrilled to be joined by Dr. Sarah Hill, an award-winning researcher, professor, and leading voice in the field of women's hormones and brain health. She wrote This Is Your Brain on Birth Control and has also authored The Period Brain, which is due to be released this fall. In our conversation, Dr. Hill dispels the myths surrounding bioidentical hormones and shares her view on how women are not biologically disordered, but just ignored by science. We dive into research on how oral contraceptives affect the brain and how the pill creates a dysregulated stress response, particularly in women with histories of adverse childhood experiences. We also explore progesterone through the lens of an evolutionary biologist and neuro-endocrinologist, highlighting its role in supporting GABAergic tone, the key differences between synthetic progestins and natural progesterone, and research on PMS and PMDD, including practical ways to manage those issues. This helpful discussion with Dr. Sarah Hill is a must-listen for women at every stage of life. IN THIS EPISODE, YOU WILL LEARN: Why has science ignored women? How oral contraceptives affect the way women perceive the world How early-life trauma impacts the ability to manage stress in adulthood Often-overlooked benefits of progesterone The different ways estrogen and progesterone impact women's ability to build muscle mass from resistance training The positive effects of the GABAergic system in the brain The problem with combined hormone therapy How progesterone gets ignored and villainized, even though it can help women experience better lives How the protective and anti-inflammatory properties of progesterone support brain health and enhance neuroplasticity What the research suggests for women experiencing severe PMS or PMDD Connect with Cynthia Thurlow   Follow on X, Instagram & LinkedIn Check out Cynthia's website Submit your questions to support@cynthiathurlow.com Connect with Dr. Sarah Hill On her website Instagram Pre-order a copy of Dr. Hill's new book, The Period Brain: The New Science of Why We PMS and How to Fix It, which will be on sale at the end of September. 

After decades of use, hormonal birth control is suddenly under the microscope. Emma Goldberg, business features writer for The New York Times, joins host Krys Boyd to discuss why birth control has become a political issue, why a growing number of women are pushing back on taking it, and how social media influencers are driving the conversation. Her article is “‘Who Am I Without Birth Control?'” Learn about your ad choices: dovetail.prx.org/ad-choices